Dawes Karen A's Form 4/A amendment
AmendedRepligen Corp (RGEN) · filed Jul 22, 2021
- Accession no.
- 0000899243-21-029533
- Filed
- Jul 22, 2021
- Trade date
- Jul 13, 2021
- Filing delay
- 9 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jul 15, 2021
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $307.4K. It was filed 9 days after the trade.
This amendment replaces 0000899243-21-028505 (filed Jul 15, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dawes Karen ACIK 0001261506 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2021 | Common Stock | MOption exerciseAcquired | +2,929 | $41.19 | +$120,645.51 | 118,982 | Direct | |
| Jul 13, 2021 | Common Stock | SSaleDisposed | −441 | $201.27F2 | −$88,760.07 | 118,541 | Direct | |
| Jul 13, 2021 | Common Stock | SSaleDisposed | −630 | $202.29F3 | −$127,442.7 | 117,911 | Direct | |
| Jul 13, 2021 | Common Stock | SSaleDisposed | −444 | $203.09F4 | −$90,171.96 | 117,467 | Direct | |
| Jul 13, 2021 | Common Stock | SSaleDisposed | −5 | $204.02F5 | −$1,020.1 | 117,462 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2021 | Common Stock | MOption exerciseAcquired | +2,929 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.
- F2
$201.27 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.77 to $201.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F3
$202.29 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.77 to $202.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F4
$203.09 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.86 to $203.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F5
$204.02 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.01 to $204.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F6
This option is fully vested and exercisable.
Remarks
This Form 4/A amends a Form 4 filed on 7/15/2021 to correct the presentation of the stock sold to reflect the multiple transactions to sell the total 1,520 shares.